Novasep does well by the FDA but PharMEDium does not; U.K. group alarmed over shortages

> A calculation by the European Compliance Agency says about 20% of FDA warning letters involve equipment issues. Report

> Strides Arcolab has gotten FDA approval to make and market capsules of the immunosuppressant Tacrolimus. Report

> Ampio Pharmaceuticals says it is about to open a facility in Colorado for manufacturing its drug candidate for osteoarthritis. Release

> Novasep says the FDA has completed its pre-approval inspections at two of its sites in Chasse-sur-Rhone and Pompey, France, authorizing it to produce a new molecular entity (NME) approved in the U.S., without specifying what one. News

> The FDA sent a warning letter to Chicago-area compounder, PharMEDium Services. Warning letter

And Finally... The All Party Pharmacy Group in the U.K. is warning about drug shortages there, saying problems continue but that wholesalers are doing a better job of handling them. Story